Medical Care
Global Macular Edema and Macular Degeneration Market Research Report 2025
- Mar 11, 25
- ID: 95860
- Pages: 79
- Figures: 79
- Views: 21
The global market for Macular Edema and Macular Degeneration was valued at US$ 9274 million in the year 2024 and is projected to reach a revised size of US$ 15080 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Macular Edema and Macular Degeneration are two distinct eye conditions that affect the macula, a small but crucial part of the retina responsible for central vision and fine detail.
The market for macular edema treatment has been witnessing advancements in therapeutic options. Anti-VEGF (vascular endothelial growth factor) injections and corticosteroid implants are commonly used to manage macular edema, and new formulations and delivery methods were being explored to enhance treatment effectiveness and patient convenience.
This report aims to provide a comprehensive presentation of the global market for Macular Edema and Macular Degeneration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macular Edema and Macular Degeneration.
The Macular Edema and Macular Degeneration market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Macular Edema and Macular Degeneration market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Macular Edema and Macular Degeneration companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd
Novartis AG
GlaxoSmithKline plc
Allergan
Regeneron Pharmaceuticals Inc
Alimera Sciences
Bausch Health Companies Inc.
Kubota Pharmaceutical Holdings Co.
Bayer AG
Segment by Type
Macular Edema
Macular Degeneration
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Macular Edema and Macular Degeneration company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Macular Edema and Macular Degeneration are two distinct eye conditions that affect the macula, a small but crucial part of the retina responsible for central vision and fine detail.
The market for macular edema treatment has been witnessing advancements in therapeutic options. Anti-VEGF (vascular endothelial growth factor) injections and corticosteroid implants are commonly used to manage macular edema, and new formulations and delivery methods were being explored to enhance treatment effectiveness and patient convenience.
This report aims to provide a comprehensive presentation of the global market for Macular Edema and Macular Degeneration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macular Edema and Macular Degeneration.
The Macular Edema and Macular Degeneration market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Macular Edema and Macular Degeneration market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Macular Edema and Macular Degeneration companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd
Novartis AG
GlaxoSmithKline plc
Allergan
Regeneron Pharmaceuticals Inc
Alimera Sciences
Bausch Health Companies Inc.
Kubota Pharmaceutical Holdings Co.
Bayer AG
Segment by Type
Macular Edema
Macular Degeneration
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Macular Edema and Macular Degeneration company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Macular Edema and Macular Degeneration Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Macular Edema
1.2.3 Macular Degeneration
1.3 Market by Application
1.3.1 Global Macular Edema and Macular Degeneration Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Macular Edema and Macular Degeneration Market Perspective (2020-2031)
2.2 Global Macular Edema and Macular Degeneration Growth Trends by Region
2.2.1 Global Macular Edema and Macular Degeneration Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Macular Edema and Macular Degeneration Historic Market Size by Region (2020-2025)
2.2.3 Macular Edema and Macular Degeneration Forecasted Market Size by Region (2026-2031)
2.3 Macular Edema and Macular Degeneration Market Dynamics
2.3.1 Macular Edema and Macular Degeneration Industry Trends
2.3.2 Macular Edema and Macular Degeneration Market Drivers
2.3.3 Macular Edema and Macular Degeneration Market Challenges
2.3.4 Macular Edema and Macular Degeneration Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Macular Edema and Macular Degeneration Players by Revenue
3.1.1 Global Top Macular Edema and Macular Degeneration Players by Revenue (2020-2025)
3.1.2 Global Macular Edema and Macular Degeneration Revenue Market Share by Players (2020-2025)
3.2 Global Macular Edema and Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Macular Edema and Macular Degeneration Revenue
3.4 Global Macular Edema and Macular Degeneration Market Concentration Ratio
3.4.1 Global Macular Edema and Macular Degeneration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Macular Edema and Macular Degeneration Revenue in 2024
3.5 Global Key Players of Macular Edema and Macular Degeneration Head office and Area Served
3.6 Global Key Players of Macular Edema and Macular Degeneration, Product and Application
3.7 Global Key Players of Macular Edema and Macular Degeneration, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Macular Edema and Macular Degeneration Breakdown Data by Type
4.1 Global Macular Edema and Macular Degeneration Historic Market Size by Type (2020-2025)
4.2 Global Macular Edema and Macular Degeneration Forecasted Market Size by Type (2026-2031)
5 Macular Edema and Macular Degeneration Breakdown Data by Application
5.1 Global Macular Edema and Macular Degeneration Historic Market Size by Application (2020-2025)
5.2 Global Macular Edema and Macular Degeneration Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Macular Edema and Macular Degeneration Market Size (2020-2031)
6.2 North America Macular Edema and Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Macular Edema and Macular Degeneration Market Size by Country (2020-2025)
6.4 North America Macular Edema and Macular Degeneration Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Macular Edema and Macular Degeneration Market Size (2020-2031)
7.2 Europe Macular Edema and Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Macular Edema and Macular Degeneration Market Size by Country (2020-2025)
7.4 Europe Macular Edema and Macular Degeneration Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Macular Edema and Macular Degeneration Market Size (2020-2031)
8.2 Asia-Pacific Macular Edema and Macular Degeneration Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Macular Edema and Macular Degeneration Market Size by Region (2020-2025)
8.4 Asia-Pacific Macular Edema and Macular Degeneration Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Macular Edema and Macular Degeneration Market Size (2020-2031)
9.2 Latin America Macular Edema and Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Macular Edema and Macular Degeneration Market Size by Country (2020-2025)
9.4 Latin America Macular Edema and Macular Degeneration Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Macular Edema and Macular Degeneration Market Size (2020-2031)
10.2 Middle East & Africa Macular Edema and Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Macular Edema and Macular Degeneration Market Size by Country (2020-2025)
10.4 Middle East & Africa Macular Edema and Macular Degeneration Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd Macular Edema and Macular Degeneration Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Macular Edema and Macular Degeneration Introduction
11.2.4 Novartis AG Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.2.5 Novartis AG Recent Development
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Details
11.3.2 GlaxoSmithKline plc Business Overview
11.3.3 GlaxoSmithKline plc Macular Edema and Macular Degeneration Introduction
11.3.4 GlaxoSmithKline plc Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.3.5 GlaxoSmithKline plc Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Macular Edema and Macular Degeneration Introduction
11.4.4 Allergan Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.4.5 Allergan Recent Development
11.5 Regeneron Pharmaceuticals Inc
11.5.1 Regeneron Pharmaceuticals Inc Company Details
11.5.2 Regeneron Pharmaceuticals Inc Business Overview
11.5.3 Regeneron Pharmaceuticals Inc Macular Edema and Macular Degeneration Introduction
11.5.4 Regeneron Pharmaceuticals Inc Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.5.5 Regeneron Pharmaceuticals Inc Recent Development
11.6 Alimera Sciences
11.6.1 Alimera Sciences Company Details
11.6.2 Alimera Sciences Business Overview
11.6.3 Alimera Sciences Macular Edema and Macular Degeneration Introduction
11.6.4 Alimera Sciences Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.6.5 Alimera Sciences Recent Development
11.7 Bausch Health Companies Inc.
11.7.1 Bausch Health Companies Inc. Company Details
11.7.2 Bausch Health Companies Inc. Business Overview
11.7.3 Bausch Health Companies Inc. Macular Edema and Macular Degeneration Introduction
11.7.4 Bausch Health Companies Inc. Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.7.5 Bausch Health Companies Inc. Recent Development
11.8 Kubota Pharmaceutical Holdings Co.
11.8.1 Kubota Pharmaceutical Holdings Co. Company Details
11.8.2 Kubota Pharmaceutical Holdings Co. Business Overview
11.8.3 Kubota Pharmaceutical Holdings Co. Macular Edema and Macular Degeneration Introduction
11.8.4 Kubota Pharmaceutical Holdings Co. Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.8.5 Kubota Pharmaceutical Holdings Co. Recent Development
11.9 Bayer AG
11.9.1 Bayer AG Company Details
11.9.2 Bayer AG Business Overview
11.9.3 Bayer AG Macular Edema and Macular Degeneration Introduction
11.9.4 Bayer AG Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.9.5 Bayer AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Macular Edema and Macular Degeneration Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Macular Edema
1.2.3 Macular Degeneration
1.3 Market by Application
1.3.1 Global Macular Edema and Macular Degeneration Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Macular Edema and Macular Degeneration Market Perspective (2020-2031)
2.2 Global Macular Edema and Macular Degeneration Growth Trends by Region
2.2.1 Global Macular Edema and Macular Degeneration Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Macular Edema and Macular Degeneration Historic Market Size by Region (2020-2025)
2.2.3 Macular Edema and Macular Degeneration Forecasted Market Size by Region (2026-2031)
2.3 Macular Edema and Macular Degeneration Market Dynamics
2.3.1 Macular Edema and Macular Degeneration Industry Trends
2.3.2 Macular Edema and Macular Degeneration Market Drivers
2.3.3 Macular Edema and Macular Degeneration Market Challenges
2.3.4 Macular Edema and Macular Degeneration Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Macular Edema and Macular Degeneration Players by Revenue
3.1.1 Global Top Macular Edema and Macular Degeneration Players by Revenue (2020-2025)
3.1.2 Global Macular Edema and Macular Degeneration Revenue Market Share by Players (2020-2025)
3.2 Global Macular Edema and Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Macular Edema and Macular Degeneration Revenue
3.4 Global Macular Edema and Macular Degeneration Market Concentration Ratio
3.4.1 Global Macular Edema and Macular Degeneration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Macular Edema and Macular Degeneration Revenue in 2024
3.5 Global Key Players of Macular Edema and Macular Degeneration Head office and Area Served
3.6 Global Key Players of Macular Edema and Macular Degeneration, Product and Application
3.7 Global Key Players of Macular Edema and Macular Degeneration, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Macular Edema and Macular Degeneration Breakdown Data by Type
4.1 Global Macular Edema and Macular Degeneration Historic Market Size by Type (2020-2025)
4.2 Global Macular Edema and Macular Degeneration Forecasted Market Size by Type (2026-2031)
5 Macular Edema and Macular Degeneration Breakdown Data by Application
5.1 Global Macular Edema and Macular Degeneration Historic Market Size by Application (2020-2025)
5.2 Global Macular Edema and Macular Degeneration Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Macular Edema and Macular Degeneration Market Size (2020-2031)
6.2 North America Macular Edema and Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Macular Edema and Macular Degeneration Market Size by Country (2020-2025)
6.4 North America Macular Edema and Macular Degeneration Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Macular Edema and Macular Degeneration Market Size (2020-2031)
7.2 Europe Macular Edema and Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Macular Edema and Macular Degeneration Market Size by Country (2020-2025)
7.4 Europe Macular Edema and Macular Degeneration Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Macular Edema and Macular Degeneration Market Size (2020-2031)
8.2 Asia-Pacific Macular Edema and Macular Degeneration Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Macular Edema and Macular Degeneration Market Size by Region (2020-2025)
8.4 Asia-Pacific Macular Edema and Macular Degeneration Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Macular Edema and Macular Degeneration Market Size (2020-2031)
9.2 Latin America Macular Edema and Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Macular Edema and Macular Degeneration Market Size by Country (2020-2025)
9.4 Latin America Macular Edema and Macular Degeneration Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Macular Edema and Macular Degeneration Market Size (2020-2031)
10.2 Middle East & Africa Macular Edema and Macular Degeneration Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Macular Edema and Macular Degeneration Market Size by Country (2020-2025)
10.4 Middle East & Africa Macular Edema and Macular Degeneration Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd Macular Edema and Macular Degeneration Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Macular Edema and Macular Degeneration Introduction
11.2.4 Novartis AG Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.2.5 Novartis AG Recent Development
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Details
11.3.2 GlaxoSmithKline plc Business Overview
11.3.3 GlaxoSmithKline plc Macular Edema and Macular Degeneration Introduction
11.3.4 GlaxoSmithKline plc Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.3.5 GlaxoSmithKline plc Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Macular Edema and Macular Degeneration Introduction
11.4.4 Allergan Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.4.5 Allergan Recent Development
11.5 Regeneron Pharmaceuticals Inc
11.5.1 Regeneron Pharmaceuticals Inc Company Details
11.5.2 Regeneron Pharmaceuticals Inc Business Overview
11.5.3 Regeneron Pharmaceuticals Inc Macular Edema and Macular Degeneration Introduction
11.5.4 Regeneron Pharmaceuticals Inc Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.5.5 Regeneron Pharmaceuticals Inc Recent Development
11.6 Alimera Sciences
11.6.1 Alimera Sciences Company Details
11.6.2 Alimera Sciences Business Overview
11.6.3 Alimera Sciences Macular Edema and Macular Degeneration Introduction
11.6.4 Alimera Sciences Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.6.5 Alimera Sciences Recent Development
11.7 Bausch Health Companies Inc.
11.7.1 Bausch Health Companies Inc. Company Details
11.7.2 Bausch Health Companies Inc. Business Overview
11.7.3 Bausch Health Companies Inc. Macular Edema and Macular Degeneration Introduction
11.7.4 Bausch Health Companies Inc. Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.7.5 Bausch Health Companies Inc. Recent Development
11.8 Kubota Pharmaceutical Holdings Co.
11.8.1 Kubota Pharmaceutical Holdings Co. Company Details
11.8.2 Kubota Pharmaceutical Holdings Co. Business Overview
11.8.3 Kubota Pharmaceutical Holdings Co. Macular Edema and Macular Degeneration Introduction
11.8.4 Kubota Pharmaceutical Holdings Co. Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.8.5 Kubota Pharmaceutical Holdings Co. Recent Development
11.9 Bayer AG
11.9.1 Bayer AG Company Details
11.9.2 Bayer AG Business Overview
11.9.3 Bayer AG Macular Edema and Macular Degeneration Introduction
11.9.4 Bayer AG Revenue in Macular Edema and Macular Degeneration Business (2020-2025)
11.9.5 Bayer AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Macular Edema and Macular Degeneration Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Macular Edema
Table 3. Key Players of Macular Degeneration
Table 4. Global Macular Edema and Macular Degeneration Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Macular Edema and Macular Degeneration Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Macular Edema and Macular Degeneration Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Macular Edema and Macular Degeneration Market Share by Region (2020-2025)
Table 8. Global Macular Edema and Macular Degeneration Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Macular Edema and Macular Degeneration Market Share by Region (2026-2031)
Table 10. Macular Edema and Macular Degeneration Market Trends
Table 11. Macular Edema and Macular Degeneration Market Drivers
Table 12. Macular Edema and Macular Degeneration Market Challenges
Table 13. Macular Edema and Macular Degeneration Market Restraints
Table 14. Global Macular Edema and Macular Degeneration Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Macular Edema and Macular Degeneration Market Share by Players (2020-2025)
Table 16. Global Top Macular Edema and Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Edema and Macular Degeneration as of 2024)
Table 17. Ranking of Global Top Macular Edema and Macular Degeneration Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Macular Edema and Macular Degeneration Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Macular Edema and Macular Degeneration, Headquarters and Area Served
Table 20. Global Key Players of Macular Edema and Macular Degeneration, Product and Application
Table 21. Global Key Players of Macular Edema and Macular Degeneration, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Macular Edema and Macular Degeneration Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Macular Edema and Macular Degeneration Revenue Market Share by Type (2020-2025)
Table 25. Global Macular Edema and Macular Degeneration Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Macular Edema and Macular Degeneration Revenue Market Share by Type (2026-2031)
Table 27. Global Macular Edema and Macular Degeneration Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Macular Edema and Macular Degeneration Revenue Market Share by Application (2020-2025)
Table 29. Global Macular Edema and Macular Degeneration Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Macular Edema and Macular Degeneration Revenue Market Share by Application (2026-2031)
Table 31. North America Macular Edema and Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Macular Edema and Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Macular Edema and Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Macular Edema and Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Macular Edema and Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Macular Edema and Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Macular Edema and Macular Degeneration Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Macular Edema and Macular Degeneration Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Macular Edema and Macular Degeneration Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Macular Edema and Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Macular Edema and Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Macular Edema and Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Macular Edema and Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Macular Edema and Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Macular Edema and Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)
Table 46. F. Hoffmann-La Roche Ltd Company Details
Table 47. F. Hoffmann-La Roche Ltd Business Overview
Table 48. F. Hoffmann-La Roche Ltd Macular Edema and Macular Degeneration Product
Table 49. F. Hoffmann-La Roche Ltd Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 50. F. Hoffmann-La Roche Ltd Recent Development
Table 51. Novartis AG Company Details
Table 52. Novartis AG Business Overview
Table 53. Novartis AG Macular Edema and Macular Degeneration Product
Table 54. Novartis AG Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 55. Novartis AG Recent Development
Table 56. GlaxoSmithKline plc Company Details
Table 57. GlaxoSmithKline plc Business Overview
Table 58. GlaxoSmithKline plc Macular Edema and Macular Degeneration Product
Table 59. GlaxoSmithKline plc Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 60. GlaxoSmithKline plc Recent Development
Table 61. Allergan Company Details
Table 62. Allergan Business Overview
Table 63. Allergan Macular Edema and Macular Degeneration Product
Table 64. Allergan Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 65. Allergan Recent Development
Table 66. Regeneron Pharmaceuticals Inc Company Details
Table 67. Regeneron Pharmaceuticals Inc Business Overview
Table 68. Regeneron Pharmaceuticals Inc Macular Edema and Macular Degeneration Product
Table 69. Regeneron Pharmaceuticals Inc Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 70. Regeneron Pharmaceuticals Inc Recent Development
Table 71. Alimera Sciences Company Details
Table 72. Alimera Sciences Business Overview
Table 73. Alimera Sciences Macular Edema and Macular Degeneration Product
Table 74. Alimera Sciences Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 75. Alimera Sciences Recent Development
Table 76. Bausch Health Companies Inc. Company Details
Table 77. Bausch Health Companies Inc. Business Overview
Table 78. Bausch Health Companies Inc. Macular Edema and Macular Degeneration Product
Table 79. Bausch Health Companies Inc. Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 80. Bausch Health Companies Inc. Recent Development
Table 81. Kubota Pharmaceutical Holdings Co. Company Details
Table 82. Kubota Pharmaceutical Holdings Co. Business Overview
Table 83. Kubota Pharmaceutical Holdings Co. Macular Edema and Macular Degeneration Product
Table 84. Kubota Pharmaceutical Holdings Co. Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 85. Kubota Pharmaceutical Holdings Co. Recent Development
Table 86. Bayer AG Company Details
Table 87. Bayer AG Business Overview
Table 88. Bayer AG Macular Edema and Macular Degeneration Product
Table 89. Bayer AG Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 90. Bayer AG Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report
List of Figures
Figure 1. Macular Edema and Macular Degeneration Picture
Figure 2. Global Macular Edema and Macular Degeneration Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Macular Edema and Macular Degeneration Market Share by Type: 2024 VS 2031
Figure 4. Macular Edema Features
Figure 5. Macular Degeneration Features
Figure 6. Global Macular Edema and Macular Degeneration Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Macular Edema and Macular Degeneration Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Macular Edema and Macular Degeneration Report Years Considered
Figure 12. Global Macular Edema and Macular Degeneration Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Macular Edema and Macular Degeneration Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Macular Edema and Macular Degeneration Market Share by Region: 2024 VS 2031
Figure 15. Global Macular Edema and Macular Degeneration Market Share by Players in 2024
Figure 16. Global Top Macular Edema and Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Edema and Macular Degeneration as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Macular Edema and Macular Degeneration Revenue in 2024
Figure 18. North America Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Macular Edema and Macular Degeneration Market Share by Country (2020-2031)
Figure 20. United States Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Macular Edema and Macular Degeneration Market Share by Country (2020-2031)
Figure 24. Germany Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Macular Edema and Macular Degeneration Market Share by Region (2020-2031)
Figure 32. China Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Macular Edema and Macular Degeneration Market Share by Country (2020-2031)
Figure 40. Mexico Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Macular Edema and Macular Degeneration Market Share by Country (2020-2031)
Figure 44. Turkey Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 48. Novartis AG Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 49. GlaxoSmithKline plc Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 50. Allergan Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 51. Regeneron Pharmaceuticals Inc Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 52. Alimera Sciences Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 53. Bausch Health Companies Inc. Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 54. Kubota Pharmaceutical Holdings Co. Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 55. Bayer AG Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Macular Edema and Macular Degeneration Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Macular Edema
Table 3. Key Players of Macular Degeneration
Table 4. Global Macular Edema and Macular Degeneration Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Macular Edema and Macular Degeneration Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Macular Edema and Macular Degeneration Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Macular Edema and Macular Degeneration Market Share by Region (2020-2025)
Table 8. Global Macular Edema and Macular Degeneration Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Macular Edema and Macular Degeneration Market Share by Region (2026-2031)
Table 10. Macular Edema and Macular Degeneration Market Trends
Table 11. Macular Edema and Macular Degeneration Market Drivers
Table 12. Macular Edema and Macular Degeneration Market Challenges
Table 13. Macular Edema and Macular Degeneration Market Restraints
Table 14. Global Macular Edema and Macular Degeneration Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Macular Edema and Macular Degeneration Market Share by Players (2020-2025)
Table 16. Global Top Macular Edema and Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Edema and Macular Degeneration as of 2024)
Table 17. Ranking of Global Top Macular Edema and Macular Degeneration Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Macular Edema and Macular Degeneration Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Macular Edema and Macular Degeneration, Headquarters and Area Served
Table 20. Global Key Players of Macular Edema and Macular Degeneration, Product and Application
Table 21. Global Key Players of Macular Edema and Macular Degeneration, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Macular Edema and Macular Degeneration Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Macular Edema and Macular Degeneration Revenue Market Share by Type (2020-2025)
Table 25. Global Macular Edema and Macular Degeneration Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Macular Edema and Macular Degeneration Revenue Market Share by Type (2026-2031)
Table 27. Global Macular Edema and Macular Degeneration Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Macular Edema and Macular Degeneration Revenue Market Share by Application (2020-2025)
Table 29. Global Macular Edema and Macular Degeneration Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Macular Edema and Macular Degeneration Revenue Market Share by Application (2026-2031)
Table 31. North America Macular Edema and Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Macular Edema and Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Macular Edema and Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Macular Edema and Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Macular Edema and Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Macular Edema and Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Macular Edema and Macular Degeneration Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Macular Edema and Macular Degeneration Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Macular Edema and Macular Degeneration Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Macular Edema and Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Macular Edema and Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Macular Edema and Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Macular Edema and Macular Degeneration Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Macular Edema and Macular Degeneration Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Macular Edema and Macular Degeneration Market Size by Country (2026-2031) & (US$ Million)
Table 46. F. Hoffmann-La Roche Ltd Company Details
Table 47. F. Hoffmann-La Roche Ltd Business Overview
Table 48. F. Hoffmann-La Roche Ltd Macular Edema and Macular Degeneration Product
Table 49. F. Hoffmann-La Roche Ltd Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 50. F. Hoffmann-La Roche Ltd Recent Development
Table 51. Novartis AG Company Details
Table 52. Novartis AG Business Overview
Table 53. Novartis AG Macular Edema and Macular Degeneration Product
Table 54. Novartis AG Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 55. Novartis AG Recent Development
Table 56. GlaxoSmithKline plc Company Details
Table 57. GlaxoSmithKline plc Business Overview
Table 58. GlaxoSmithKline plc Macular Edema and Macular Degeneration Product
Table 59. GlaxoSmithKline plc Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 60. GlaxoSmithKline plc Recent Development
Table 61. Allergan Company Details
Table 62. Allergan Business Overview
Table 63. Allergan Macular Edema and Macular Degeneration Product
Table 64. Allergan Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 65. Allergan Recent Development
Table 66. Regeneron Pharmaceuticals Inc Company Details
Table 67. Regeneron Pharmaceuticals Inc Business Overview
Table 68. Regeneron Pharmaceuticals Inc Macular Edema and Macular Degeneration Product
Table 69. Regeneron Pharmaceuticals Inc Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 70. Regeneron Pharmaceuticals Inc Recent Development
Table 71. Alimera Sciences Company Details
Table 72. Alimera Sciences Business Overview
Table 73. Alimera Sciences Macular Edema and Macular Degeneration Product
Table 74. Alimera Sciences Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 75. Alimera Sciences Recent Development
Table 76. Bausch Health Companies Inc. Company Details
Table 77. Bausch Health Companies Inc. Business Overview
Table 78. Bausch Health Companies Inc. Macular Edema and Macular Degeneration Product
Table 79. Bausch Health Companies Inc. Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 80. Bausch Health Companies Inc. Recent Development
Table 81. Kubota Pharmaceutical Holdings Co. Company Details
Table 82. Kubota Pharmaceutical Holdings Co. Business Overview
Table 83. Kubota Pharmaceutical Holdings Co. Macular Edema and Macular Degeneration Product
Table 84. Kubota Pharmaceutical Holdings Co. Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 85. Kubota Pharmaceutical Holdings Co. Recent Development
Table 86. Bayer AG Company Details
Table 87. Bayer AG Business Overview
Table 88. Bayer AG Macular Edema and Macular Degeneration Product
Table 89. Bayer AG Revenue in Macular Edema and Macular Degeneration Business (2020-2025) & (US$ Million)
Table 90. Bayer AG Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report
List of Figures
Figure 1. Macular Edema and Macular Degeneration Picture
Figure 2. Global Macular Edema and Macular Degeneration Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Macular Edema and Macular Degeneration Market Share by Type: 2024 VS 2031
Figure 4. Macular Edema Features
Figure 5. Macular Degeneration Features
Figure 6. Global Macular Edema and Macular Degeneration Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Macular Edema and Macular Degeneration Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Macular Edema and Macular Degeneration Report Years Considered
Figure 12. Global Macular Edema and Macular Degeneration Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Macular Edema and Macular Degeneration Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Macular Edema and Macular Degeneration Market Share by Region: 2024 VS 2031
Figure 15. Global Macular Edema and Macular Degeneration Market Share by Players in 2024
Figure 16. Global Top Macular Edema and Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Edema and Macular Degeneration as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Macular Edema and Macular Degeneration Revenue in 2024
Figure 18. North America Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Macular Edema and Macular Degeneration Market Share by Country (2020-2031)
Figure 20. United States Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Macular Edema and Macular Degeneration Market Share by Country (2020-2031)
Figure 24. Germany Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Macular Edema and Macular Degeneration Market Share by Region (2020-2031)
Figure 32. China Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Macular Edema and Macular Degeneration Market Share by Country (2020-2031)
Figure 40. Mexico Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Macular Edema and Macular Degeneration Market Share by Country (2020-2031)
Figure 44. Turkey Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Macular Edema and Macular Degeneration Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 48. Novartis AG Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 49. GlaxoSmithKline plc Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 50. Allergan Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 51. Regeneron Pharmaceuticals Inc Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 52. Alimera Sciences Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 53. Bausch Health Companies Inc. Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 54. Kubota Pharmaceutical Holdings Co. Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 55. Bayer AG Revenue Growth Rate in Macular Edema and Macular Degeneration Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232